Dr Sai Praveen Haranath is a physician working at Apollo Hospitals and Medical Director of one of the first Tele ICU programs in India- eACCESS
Consultant Intensivist and Pulmonologist,Apollo Hospitals, Jubilee Hills, Hyderabad, India
Awards and Achievements
Humanitarian Award from University of Connecticut Health Center, USA and the Governors Community Service Award from the American College of Chest Physicians .
Completed the Johns Hopkins Bloomberg School of Public Health Tobacco Control Leadership Program
He has been involved in multiple presentations and conferences in India and abroad.
He is interested in all things digital and loves a good game of table tennis .
He believes in honest communication with patients and families and feels that healthcare has spiritual overtones.
He has significant experience in t for the practical delivery of ethical healthcare .
His prior experiences in rural, community and academic medical centres in the US including The Permanente Medical Group/Kaiser Permanente in the San Francisco area ,his US and India teleICU experience and his current position at Apollo Hospitals in Hyderabad make him an expert in helping patients with complex medical conditions.
Active in ACCP volunteer leadership
Clinic Director , Apollo LAM Clinic , Part of the LAM Foundation International Clinic Network
Research and Publications
Peer reviewed publications in international journals:
Panigrahi N, Haranath SP, Ma A, Srinivas Y, Sirga S, Ramkumar, K S. Cyanide Toxicity!! Colour of Blood Says It All. Indian J Crit Care Med. 2019 Mar;23(3):155-156. doi: 10.5005/jp-journals-10071-23141. PMID: 31097895; PMCID: PMC6487624.
Haranath SP. Lessons from Haiti. Perm J. 2011 Winter;15(1):86. PMID: 21505633; PMCID: PMC3048649.
Haranath SP, Meeta M. COVID-19: The Vital Sign. J Midlife Health.2020 Oct - Dec;11(4):199. doi: 10.4103/jmh.jmh_286_20. Epub 2021 Jan 21. PMID: 33767559; PMCID: PMC7978048.
Haranath SP, Ganapathy K, Kesavarapu SR, Kuragayala SD.eNeuroIntensive Care in India: The Need of the Hour. Neurol India.2021 Mar-Apr;69(2):245-251. doi: 10.4103/0028-3886.314591. PMID:33904432.
Haranath SP, Jakkinaboina S. Is proton pump inhibitor use a significant confounder for chromogranin A levels in sepsis? Intensive Care Med. 2012 Nov;38(11):1901; author reply 1902-3. doi: 10.1007/s00134-012-2664-3.Epub 2012 Aug 15. PMID: 22893219.
Haranath SP, Park BS, Osborne M. Body mass index in COPD mortality: is it all in the water? Chest. 2008 Jan;133(1):318-9. author reply 319. doi: 10.1378/chest.07-2285. PMID: 18187768.
Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker A, Haranath SP, Pauwels RA, Kips JC, Drazen JM. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest. 2000 Mar;117(3):708-13. doi:10.1378/chest.117.3.708. PMID: 10712995.
Kar S, Chawla R, Haranath SP, Ramasubban S, Ramakrishnan N, Vaishya R, Sibal A, Reddy S. Multivariable mortality risk prediction using
machine learning for COVID-19 patients at admission (AICOVID). Sci Rep. 2021 Jun 17;11(1):12801. doi:10.1038/s41598-021-92146-7. PMID:34140592; PMCID: PMC8211710.
Haranath SP, Grines C. Percutaneous coronary intervention for acute myocardial infarction: current strategy in the lab. Indian Heart J. 2007 Mar-Apr;59(2 Suppl B):B86-98. PMID: 19153441.
Haranath SP. Prevention of hip fracture with use of a hip protector. N Engl J Med. 2001 Mar 15;344(11):856; author reply 856-7. PMID: 11252312.